| 1 |
35078524 | Fifteen years of enzyme replacement therapy for mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a case report. | 2022 Jan 25 |
1 |
| 2 |
33985463 | Compound heterozygous missense mutations in a Chinese mucopolysaccharidosis type VI patient: a case report. | 2021 May 13 |
1 |
| 3 |
34435740 | Deep intronic variant in the ARSB gene as the genetic cause for Maroteaux-Lamy syndrome (MPS VI). | 2021 Dec |
3 |
| 4 |
34948256 | Mucopolysaccharidosis Type VI, an Updated Overview of the Disease. | 2021 Dec 15 |
1 |
| 5 |
35118118 | Epidemiology and Genetics of Mucopolysaccharidosis Type VI in Russia. | 2021 |
2 |
| 6 |
29371215 | Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling. | 2018 Jun 5 |
1 |
| 7 |
29762123 | Identification of a critical sulfation in chondroitin that inhibits axonal regeneration. | 2018 May 15 |
2 |
| 8 |
26450354 | Long-term cognitive follow-up in children treated for Maroteaux-Lamy syndrome. | 2016 Mar |
1 |
| 9 |
26656789 | Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells. | 2016 Feb |
1 |
| 10 |
27078017 | Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF. | 2016 |
2 |
| 11 |
25190157 | [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI]. | 2014 Jun |
1 |
| 12 |
22550062 | Reduced Arylsulfatase B activity in leukocytes from cystic fibrosis patients. | 2013 Mar |
3 |
| 13 |
24107440 | Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome. | 2013 Sep 5 |
2 |
| 14 |
22289849 | Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats. | 2012 Jan |
1 |
| 15 |
22428001 | Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia. | 2012 |
1 |
| 16 |
21378286 | Extra-lysosomal localization of arylsulfatase B in human colonic epithelium. | 2011 Mar |
3 |
| 17 |
21813902 | Enzyme replacement therapy for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): experience in Hong Kong. | 2011 Aug |
1 |
| 18 |
21930407 | Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI. | 2011 Dec |
2 |
| 19 |
20036175 | Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis. | 2010 Apr |
2 |
| 20 |
20800524 | Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): a single dose of galsulfase further reduces urine glycosaminoglycans after hematopoietic stem cell transplantation. | 2010 Dec |
4 |
| 21 |
18418554 | Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapy. | 2009 Aug |
1 |
| 22 |
19682969 | Development of a functional bioassay for arylsulfatase B using the natural substrates of the enzyme. | 2009 Dec 15 |
5 |
| 23 |
17672828 | Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease. | 2008 Mar |
3 |
| 24 |
18285341 | Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates. | 2008 Apr 11 |
1 |
| 25 |
17458871 | Mutational analysis of 105 mucopolysaccharidosis type VI patients. | 2007 Sep |
3 |
| 26 |
16549525 | Intra-articular enzyme administration for joint disease in feline mucopolysaccharidosis VI: enzyme dose and interval. | 2006 Apr |
1 |
| 27 |
11668612 | Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase. | 2001 Oct |
2 |
| 28 |
9268591 | Age-related increase in activity of specific lysosomal enzymes in the human retinal pigment epithelium. | 1997 Aug |
1 |
| 29 |
9364929 | Feline mucopolysaccharidosis type VI: correction of glycosaminoglycan storage in myoblasts by retrovirus-mediated transfer of the feline N-acetylgalactosamine 4-sulfatase gene. | 1997 Oct |
1 |
| 30 |
8755662 | Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy. | 1996 Jul 15 |
6 |
| 31 |
1427856 | Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1. | 1992 Oct |
2 |
| 32 |
1784840 | Inhibition of arylsulfatase B by ascorbic acid. | 1991 Aug |
1 |